Research and experimentation expenditures constitute the financial investments made by a taxpayer for activities intended to discover information that eliminates technical uncertainty regarding the development of a product or process. Under Rhode Island law, these expenditures serve as the primary metric for calculating tax credits designed to incentivize domestic innovation and high-value job creation within the state's borders.

The legal and economic landscape of the Rhode Island Research and Development (R&D) tax credit is a sophisticated intersection of federal definitions, state-specific statutory modifications, and recent administrative decoupling necessitated by federal legislative shifts. To understand the meaning of Research and Experimentation (R&E) expenditures in this context, one must analyze the dual nature of the credit system, which separates investments in tangible property from the recurring operational costs of qualified research activities. This distinction is vital because Rhode Island provides two primary mechanisms for recovery: the R&D Property Credit and the Qualified Research Expense Credit. These incentives are not merely static deductions but are dynamic instruments of tax policy that have evolved significantly since their inception on July 1, 1994, reflecting the state's strategic intent to remain a hub for technological and scientific advancement.

The Definitive Scope of Research and Experimentation Expenditures

The term "Research and Experimentation" is not defined in a vacuum but is anchored to the rigorous standards of the Internal Revenue Code (IRC). Rhode Island explicitly adopts the definitions set forth in 26 U.S.C. § 41, which governs the federal credit for increasing research activities. At its core, an expenditure qualifies only if it is incurred in the "experimental or laboratory sense". This qualitative threshold excludes a wide range of standard business activities, focusing the incentive on true technical innovation.

The Four-Part Test of Qualified Research

For an expenditure to be recognized as part of a qualified research activity in Rhode Island, it must satisfy the federal four-part test. This framework ensures that the state does not subsidize routine business functions but rather targets projects with genuine technical risk and potential for scientific discovery.

This structural adherence to IRC § 41 means that the meaning of R&E expenditures in Rhode Island is functionally synonymous with the federal definition of "Qualified Research Expenses" (QREs), provided those expenses are incurred within the state. However, the state introduces its own layer of complexity through its specific treatment of "base period" expenses, which are used to measure the incremental growth in research investment.

Distinguishing Qualifying from Non-Qualifying Activities

Rhode Island General Laws and the Division of Taxation guidance explicitly delineate what does not constitute research and development in the experimental sense. The distinction is critical for compliance, as including non-qualifying costs can lead to the disallowance of the entire credit.

The exclusion of research conducted after the start of commercial production is a notable "bright-line" rule in the Rhode Island context. Once a product is ready for the market and its functional design is finalized, further costs related to its manufacture or routine refinement are considered ordinary business expenses rather than R&E expenditures.

Statutory Foundations: The Rhode Island General Laws

The architecture of the R&D tax credit is built upon three primary sections of Title 44 of the Rhode Island General Laws. Each section addresses a different facet of the innovation lifecycle, from the physical facility to the personnel performing the work.

R.I. Gen. Laws § 44-32-1: Elective Deduction for Facilities

Before a business can claim a credit for research expenses, it must have a place to conduct that research. Section 44-32-1 provides an "elective deduction" against allocated net income for the construction or acquisition of new research and development facilities. This is a one-year write-off of the expenditures paid or incurred during the taxable year for the construction or acquisition of property used for R&D in the experimental sense.

A taxpayer electing this deduction must compute their entire net income for the current and succeeding years without any deduction for depreciation on the same property. This "one-year write-off" is an alternative to standard depreciation and cannot be used in conjunction with the property credit under § 44-32-2. This section is particularly beneficial for capital-intensive industries, such as biotechnology or advanced manufacturing, that require specialized laboratory environments.

R.I. Gen. Laws § 44-32-2: The R&D Property Credit

The Property Credit is a 10% incentive based on the cost or federal tax basis of tangible personal property acquired, constructed, or reconstructed after July 1, 1994. To be eligible, the property must be depreciable under IRC § 167, have a useful life of three years or more, and have a situs in Rhode Island.

The statute specifically includes buildings and structural components of buildings, provided they are used "principally" for R&D purposes. This "principally" requirement is strictly interpreted by the Division of Taxation. If a building houses both R&D and administrative functions, only the portion of the cost attributable to the R&D area may qualify, and even then, only if the primary use of the structure is research-oriented.

R.I. Gen. Laws § 44-32-3: The Qualified Research Expense Credit

This is the flagship incentive for Rhode Island's innovation economy. It provides a tiered credit for the incremental increase in QREs over a base period amount. The tiered rates are designed to offer a higher percentage of relief for initial research investments, making the credit accessible to startups and smaller firms while still providing significant value to large-scale research operations.

The statute defines the credit as 22.5% of the first $25,000 worth of credit and 16.9% for the amount of credit above that threshold. However, in practical application and administrative forms, these tiers are often expressed in terms of the underlying expenditures: 22.5% for expenditures up to $111,111 and 16.9% for the remaining expenditures above that amount.

Operational Expenditure Categories

To calculate the credit under § 44-32-3, a taxpayer must aggregate four specific categories of "qualified research expenses." These expenses must be incurred in Rhode Island to be included in the state calculation, even if the same expenses qualify for the federal R&D credit.

Wage Expenditures

Wages are the most significant component of most R&D claims. They include the portion of an employee's W-2 Box 1 wages that are attributable to "qualified services". These services encompass three levels of involvement:

• Direct Research: The actual conduct of experimentation or development by scientists, engineers, and software architects.
• Direct Supervision: The technical oversight of the research process by project managers.
• Direct Support: The work of lab assistants or technicians who maintain equipment or build prototypes used in the experimental process.

If an employee spends 80% or more of their time on qualified services, 100% of their wages may be treated as a QRE under federal rules adopted by Rhode Island.

Supply Expenditures

This category includes non-depreciable tangible property consumed during the research process. Common examples include chemical reagents, electronic components for prototype circuit boards, and materials used to construct a pilot model that will be discarded or destroyed during testing. General administrative supplies, utilities, and land are strictly excluded.

Contract Research Expenditures

When a business outsources research to a third party, such as a university or a private testing lab, only 65% of the payment is considered a qualifying expenditure. This statutory reduction is intended to prevent the credit from subsidizing the contractor's profit margin and overhead. For the Rhode Island credit, the third party must physically perform the work within the state.

Computer Leasing and Rental Expenditures

Expenses for leasing computers used for qualified research are eligible. In the current technological environment, this has been expanded through guidance to include cloud computing service costs, such as AWS or Azure instances used specifically for R&D testing environments.

Incremental Calculation and the Base Amount Mechanism

The Rhode Island R&D Expense Credit is "incremental," meaning it is calculated based on the taxpayer's research effort that exceeds a historical benchmark. This benchmark is the "base period research expenses," which Rhode Island defines in accordance with IRC § 41.

Determining the Base Amount

For established companies, the base amount is generally the average of the qualified research expenses incurred in Rhode Island over the three taxable years preceding the credit year. For startups or firms with no history of research in the state, the base amount is zero for the first year, making the entire current year expenditure eligible for the credit.

The Division of Taxation clarified a critical aspect of this calculation in Ruling Request No. 95-05. The ruling addressed whether a taxpayer with a short tax year (less than 12 months) must prorate their base amount. The Tax Administrator ruled that § 44-32-3 does not provide for or require proration. Instead, the determinative factor is simply the actual amount of federal excess expenses that were incurred in Rhode Island after July 1, 1994.

The Tiered Calculation Logic

Once the "excess" expenses are determined (Current Year RI QREs minus Base Amount), the tiered rates are applied. This tiered system is unique to Rhode Island and differs from the flat 20% rate typically found in the federal regular research credit.

This structure creates a weighted incentive that heavily favors smaller research budgets while still providing a substantial 16.9% benefit for large-scale enterprise R&D.

The 2025 Decoupling: Rhode Island vs. H.R. 1 (OBBBA)

The most significant shift in the meaning and treatment of R&E expenditures in Rhode Island occurred in July 2025. With the passage of the federal "One Big Beautiful Bill Act" (OBBBA), or H.R. 1, the federal government fundamentally altered IRC § 174.

Federal Shift to IRC § 174A

H.R. 1 introduced a new section, 174A, which restored the ability for businesses to immediately "expense" (deduct 100% of) domestic R&E expenditures in the year they are incurred, effective for tax years beginning after December 31, 2024. This was a reversal of the 2017 Tax Cuts and Jobs Act requirement to amortize such costs over five years. Furthermore, H.R. 1 allowed small businesses (gross receipts under $31 million) to retroactively expense unamortized amounts from 2022 to 2024.

Rhode Island's Proactive Decoupling Strategy

Recognizing that immediate federal expensing would drastically reduce state taxable income—with an estimated revenue loss of $65.8 million—the Rhode Island General Assembly and the Division of Taxation moved to decouple from these provisions. This policy choice was formalized in the Fiscal Year 2026 Budget and subsequent Advisory 2025-18.

As a result, for Rhode Island tax purposes, R&E expenditures must still be amortized over five years for domestic research and 15 years for foreign research, regardless of how they are treated on the federal return. This creates a "book-tax difference" that requires specific adjustments on the state return.

Mandatory Add-Backs and New Schedules

The Division of Taxation has introduced two critical new schedules to manage this decoupling for the 2025 tax year and beyond:

• RI Schedule HR1 - Entity: This is used to "add back" the accelerated deduction taken at the federal level. If a taxpayer fully expenses $1,000,000 in R&E federally, they must add that amount back to their Rhode Island net income.
• RI Schedule 174A - Amortization Worksheet: This worksheet allows the taxpayer to calculate the permitted Rhode Island deduction. Using the same $1,000,000 example, the taxpayer would be allowed a 20% amortization deduction ($200,000) on Schedule 174A.

The net effect is an increase in Rhode Island taxable income by the difference between the federal expensing and the state-mandated amortization. Over a five-year period, the taxpayer will eventually deduct the full amount for state purposes, but they do not get the "cash flow" benefit of the immediate federal write-off.

State Revenue Office Guidance: Compliance and Administration

The Rhode Island Division of Taxation oversees the administration of these credits with a focus on rigorous documentation and specific filing procedures. Unlike some state incentives that require pre-certification, the R&D credits are generally "by right" if the statutory criteria are met, but they are subject to intensive post-filing audit.

The Role of Form RI-7695E

To claim the expense credit, corporations must file Form RI-7695E. This form serves as the mathematical bridge between the federal Form 6765 and the Rhode Island tax return.

Documentation and Audit Standards

The Division of Taxation's guidance, as seen in Schedule B-CR instructions, emphasizes that "complete documentation" must be submitted with the return. For R&E expenditures, this includes:

• Detailed technical reports or project summaries explaining how the research met the four-part test.
• Wage allocation spreadsheets identifying RI-based employees and their qualifying hours.
• Vendor invoices for Rhode Island-based contract research.
• Evidence of the physical location (situs) of the research and the property.

Taxpayers who fail to attach these records can expect their credit to be disallowed upon initial processing, requiring a manual appeal or a letter of good standing request to rectify.

Utilization Limits and the "Order of Credits"

Earning a Rhode Island R&D tax credit does not necessarily mean the taxpayer can use it immediately. The state imposes several "guardrails" to protect general fund revenue.

The 50% Tax Liability Cap

Section 44-32-3(c) mandates that the credit shall not reduce the tax due for the year by more than 50% of the taxpayer's liability. This limit is calculated after other credits have been applied, which often leaves the R&D credit as the "marginal" incentive that is carried forward to future years.

The Minimum Tax Floor and Entity Charges

For corporations, the credit cannot reduce the tax due to less than the minimum tax fixed by § 44-11-2(e). For the 2025 and 2026 tax periods, this minimum is $400.

Pass-through entities, such as LLCs, S-corps, and partnerships, are also subject to a $400 annual fee or charge. While these entities do not pay corporate income tax themselves, the $400 floor applies when the credits "flow through" to the owners' personal income tax returns or when calculating the entity-level tax for firms that elect to pay at the entity level.

Carryover and Expiration

Any unused credit can be carried forward for a maximum of seven years. This is a critical strategic consideration, as the federal carryforward is 20 years. Businesses with high R&D intensity but low current-year tax liability must carefully track the "vintage" of their credits to ensure they do not expire.

Statutory Priority (The Ordering Rule)

Rhode Island law establishes a strict hierarchy for the application of business credits. If a taxpayer has multiple incentives, they must be used in the following order:

1. Investment Tax Credit (§ 44-31-1).
2. R&D Property Credit (§ 44-32-2).
3. Qualified Research Expense Credit (§ 44-32-3).

This ordering reflects the state's preference for permanent capital investment (Property Credit) over operational spending (Expense Credit).

Specialized Industry Provisions: Insurance Companies

A unique feature of Rhode Island's R&D tax law is the specific inclusion of property and casualty insurance companies. Sections 44-32-2(b) and 44-32-3(b)(2) state that "qualified research expenses" and "R&D property" include amounts expended by these companies for research into "methods and ways of preventing or reducing losses from fire and other perils".

This provision allows insurance firms to claim credits for actuarial or engineering studies that improve building safety and fire prevention, even if such activities might not satisfy the traditional "hard science" laboratory test in other industries. This reflects Rhode Island's historical position as a center for the insurance industry and a desire to encourage public-safety-oriented innovation.

Entity-Level Treatment and Combined Reporting

Rhode Island's transition to mandatory combined reporting for certain corporate groups has introduced additional layers of complexity to the R&D credit calculation.

The "Qualified Entity Only" Rule

In a consolidated or combined return, the R&D credit is allowed only against the tax of the specific corporation that generated the expenses. It cannot be used to offset the tax of an affiliate within the group that is not itself performing R&D in Rhode Island. This "siloing" of the credit requires practitioners to maintain detailed records for each subsidiary within the group.

Pass-Through Entity (PTE) Election

Effective for tax years beginning on or after January 1, 2025, a pass-through entity making the election to pay state income tax at the entity level must calculate its credit carefully. The state tax credit for these entities is calculated at 90% of the amount of tax paid by the PTE at the entity level, and the R&D credits must be factored into this net calculation before the 90% pass-through to owners is determined.

Detailed Practical Example: The 2025 Compliance Cycle

To illustrate the interplay of these rules, consider "Narragansett Bio-Tech," a C-corporation headquartered in Providence. For the 2025 calendar year, the firm has the following financials:

• Total Federal QREs: $1,200,000.
• Rhode Island QREs (all incurred at the Providence lab): $1,000,000.
• Rhode Island Base Period (3-year average): $600,000.
• Total RI Tax Liability (before credits): $100,000.

Step 1: Calculate the Generated Expense Credit

The first task is determining the "Rhode Island Excess" and applying the tiers:

• Excess: $1,000,000 (Current QRE) - $600,000 (Base) = $400,000.
• Tier 1: $111,111 * 22.5% = $24,999.98.
• Tier 2: ($400,000 - $111,111) * 16.9% = $288,889 * 16.9% = $48,822.24.
• Total Generated Credit: $24,999.98 + $48,822.24 = $73,822.22.

Step 2: Address the OBBBA/H.R. 1 Decoupling

Narragansett Bio-Tech fully expenses its $1,200,000 in R&E on Federal Form 1120.

• RI Schedule HR1: The firm must add back the $1,200,000 to Rhode Island net income.
• RI Schedule 174A: The firm calculates its Rhode Island-allowed 2025 amortization. Assuming a mid-year convention, this might be 10% or 20% depending on final regulation. At a standard 20% annual rate, the firm deducts $200,000 for RI purposes ($1M RI costs / 5 years).
• Net Impact: Taxable income increases by $1,000,000 in the current year, but the firm will get $200,000 deductions in each of the next four years.

Step 3: Apply Utilization Limits

With a pre-credit tax liability of $100,000:

• 50% Cap: The maximum credit allowed in 2025 is $50,000 ($100,000 * 50%).
• Realized Credit: The firm uses $50,000 of its generated $73,822.22.
• Final Tax Due: $100,000 - $50,000 = $50,000.
• Carryforward: $23,822.22 remains available to be used over the next seven years.

Future Outlook and Strategic Implications

The meaning of R&E expenditures in Rhode Island is currently in a state of flux due to the federal-state divergence. While the basic definition of what qualifies as research remains stable—rooted in the IRC § 41 "experimental sense"—the timing of when those costs are recognized for tax purposes has become a major point of contention.

Complexity for Taxpayers

The proactive decoupling by Rhode Island adds a significant layer of administrative friction. Businesses must now maintain parallel amortization schedules: one for federal (immediate expensing) and one for Rhode Island (five-year capitalization). This may inadvertently discourage small firms from pursuing the credit due to the cost of compliance, despite the high 22.5% incentive rate intended to support them.

Revenue Preservation vs. Innovation

Rhode Island's policy reflects a delicate balance. By decoupling, the state avoids a nearly $80 million total revenue shock from various H.R. 1 provisions, but it does so at the risk of appearing less competitive than states that follow federal rolling conformity. As other states in the Northeast evaluate their own responses to the "One Big Beautiful Bill Act," Rhode Island's aggressive stance will likely serve as a case study for revenue-neutral tax policy in an era of federal volatility.

Final Thoughts

The meaning of Research and Experimentation Expenditures in the context of the Rhode Island R&D tax credit is defined by technical rigor, geographic specificity, and a complex interplay with federal law. While the state continues to incentivize in-state innovation through generous tiered rates and a 10% property credit, the 2025 decoupling from federal expensing introduces new requirements for amortization and mandatory add-backs. For professional tax practitioners and corporate leaders, navigating this environment requires a precise understanding of R.I. Gen. Laws §§ 44-32-1 through 44-32-3, a robust documentation strategy for RI-based research activities, and a careful application of the new Schedule 174A to manage the growing gap between federal and state tax accounting. The Rhode Island R&D framework remains a powerful tool for growth, provided that businesses adapt to the heightened compliance standards and administrative guidance issued by the Division of Taxation.